Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Tinea capitis is a common scalp infection causing hair loss, mostly in young children.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Finasteride works best in 6 months and lasts 6 years.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Caffeine applied to the scalp can protect hair follicles from UV damage.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Thymosin β4 helps improve skin healing and reduce scarring.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

The document suggests changing medical education to balance generalists and specialists, focusing on patient needs.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.